Obesity doesn't look the same at age 15 as it does at age 45, and Duke University School of Medicine researchers are learning ...
Welltica+ on MSN
If you have sleep apnea and obesity, Zepbound may cut breathing disruptions by 60 percent
A weekly injection just outperformed placebo in the first Phase 3 drug trials for obstructive sleep apnea.
YouTube on MSN
Will Reta rewrite obesity?
Retatrutide is being hailed as a “trillion-dollar” weight-loss breakthrough that also spares muscle. Is this really the holy ...
Announcing a new article publication for Cardiovascular Innovations and Applications journal. Obesity, given its strong ...
GLP-1 drugs have moved rapidly into the mainstream, but recent data show that many ideal patients are still being left behind ...
Adding waist-based central obesity measures to BMI may improve the identification of risk for multimorbidity in adults with ...
Abacus Health Solutions is among the first organizations in the obesity care industry to report objective, long-term weight loss maintenance outcomes. While weight loss results have become ...
5d
Study finds extreme obesity common among bariatric surgery patients, should not preclude treatment
Patients with extreme obesity are more common among those undergoing metabolic and bariatric surgery than previously ...
Current leaders Eli Lilly and Novo Nordisk have cornered the early market for weight loss therapeutics, but several other ...
The startup combines advanced diagnostics, AI, and multidisciplinary clinical care to personalise obesity drug treatment, ...
For $190 million up front and as much as $2.3 billion overall, the Swiss drugmaker is building its portfolio with a shot that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results